Related Experiment Videos
The hypouricemic effect of chlorprothixene
A Shalev1, H Hermesh, H Munitz
1Gehah Psychiatric Hospital, Beilinson Medical Center, Petah-Tikva, Israel.
Clinical Pharmacology and Therapeutics
|November 1, 1987
Summary
Chlorprothixene, a major tranquilizer, significantly lowers serum uric acid levels in psychiatric patients. This hypouricemic effect is rapid, reversible, and occurs regardless of patient characteristics or other medications.
Area of Science:
- Pharmacology
- Nephrology
- Psychiatry
Background:
- Chlorprothixene is a thioxanthene-class major tranquilizer.
- Its potential effects on uric acid metabolism were previously unevaluated.
- Understanding drug effects on metabolic parameters is crucial in patient management.
Purpose of the Study:
- To evaluate the hypouricemic effect of chlorprothixene in psychiatric patients.
- To assess the impact of chlorprothixene on uric acid and kidney function markers.
Main Methods:
- Serum uric acid, urea, and creatinine levels were measured in 30 patients.
- Creatinine and uric acid clearance were assessed before and during treatment.
- Patients received chlorprothixene as part of their regular psychiatric treatment.
Main Results:
- Chlorprothixene demonstrated a significant uricosuric effect, similar to probenecid.
- Hypouricemia was observed in all patients within 24 hours of treatment initiation.
- Serum uric acid levels stabilized at approximately 48% of baseline within 10 days.
- The hypouricemic effect was reversible within 10 days after discontinuing chlorprothixene.
Conclusions:
- Chlorprothixene induces a potent, rapid-onset, and reversible hypouricemic effect.
- This effect is consistent across diverse patient demographics and co-administered drugs.
- Chlorprothixene's uricosuric properties warrant consideration in clinical practice, particularly regarding uric acid management.